首页> 外文会议>International Pharmaceutical Symposium >The retention rule of -elemene preparations in tumor
【24h】

The retention rule of -elemene preparations in tumor

机译:肿瘤中的-ELEMENE制剂的保留规则

获取原文

摘要

Abstract Aim: To investigate the tumor retention of -elemene preparations. Methods: H22 mouse tumor model was established, concentration of -elemene was determined by RP-HPLC. Results: After intratumoral administration, the concentration of the -elemene preparation groups Call keep invariably in 1-8h. The average concentration of the SLN group is 63.3μg·g<-1,and that of the emulsion group is 28.1μg·g-1, the concentration of the -elemene in tumor and blood are 16μg·g-1 and 2.4μg·g-1 1h after intravenous injection. Conclusions: Compared、with the emulsion, SLN is more suitable for intratumoral administration,and concentrations of both formulations after intratumoral administration are significantly higher than that of intravenous injection.
机译:摘要目的:探讨-ELEMENE制剂的肿瘤保留。方法:确定H22小鼠肿瘤模型,通过RP-HPLC测定-ELEMENE的浓度。结果:在肿瘤内给药后,-ELEMENE制备组的浓度在1-8h中总是保持不变。 SLN组的平均浓度为63.3μg·g <-1,乳液基团的浓度为28.1μg·g-1,肿瘤和血液中的浓度为16μg·g-1和2.4μg·静脉注射后G-1 1H。结论:与乳液相比,SLN更适合于肿瘤内给药,肿瘤内给药后的两种配方的浓度明显高于静脉注射液。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号